I have to take a simple approach to this..In Dec of 05 prior
to approval, INSM was a 2.50 stock. Always with the specter
of litigation hanging over it's head. Jump forward a little
over a year, and INSM now again has no approved drug, but also
no threat of a lawsuit, but the promise of many indications.
Tomorrow is a push easy..